OpenVSafe by OpenVAERS
Search V-safe

WTN-54861-38222

3 vaccinations 6 coded responses 35 check-ins 3 free-text entries 4 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
210 / MD
Registered
2022-06-20
Relationship
Child or adolescent in my care
Guardian
WLX-14118-65424
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-20
    Registered in v-safe
  2. 2022-08-04
    Dose 1 — Moderna
  3. 2022-08-04
    Health check-in — day 0, dose 1, under 3
    Feeling: Fair · Site: Pain · Irritability/crying · Be unable to do your normal daily activities
    Under 3 check-in
  4. 2022-08-05
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Fair · Site: Pain · Sleepiness
    Under 3 check-in
  5. 2022-08-07
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Irritability/crying
    Under 3 check-in
  6. 2022-08-08
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Fair · Sleepiness, Irritability/crying
    Under 3 check-in
  7. 2022-08-10
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Fair · Sleepiness, Irritability/crying
    Under 3 check-in
  8. 2022-08-11
    Survey response — day 7, dose 1, under 3
    MedDRA: Constipation — Feeling: Fair · Sleepiness, Irritability/crying
    Free text: Constipation, but she also just started solids.
    MedDRA releases: 2024-11 · check-in free text available
  9. 2022-08-18
    Health check-in — day 14, dose 1, under 3
    Feeling: Fair
    Under 3 check-in
  10. 2022-08-27
    Health check-in — day 21, dose 1, under 3
    Feeling: Fair
    Under 3 check-in
  11. 2022-09-01
    Dose 2 — Moderna
  12. 2022-09-01
    Health check-in — day 0, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  13. 2022-09-03
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Site: Pain, Redness, Swelling/hardness · Irritability/crying, Rash, not including the immediate area around the injection site
    Under 3 check-in
  14. 2022-09-04
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Site: Pain · Irritability/crying, Rash, not including the immediate area around the injection site
    Under 3 check-in
  15. 2022-09-05
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Site: Pain · Irritability/crying, Rash, not including the immediate area around the injection site
    Under 3 check-in
  16. 2022-09-06
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Sleepiness, Irritability/crying, Rash, not including the immediate area around the injection site
    Under 3 check-in
  17. 2022-09-07
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Irritability/crying
    Under 3 check-in
  18. 2022-09-08
    Health check-in — day 7, dose 2, under 3
    Feeling: Fair · Irritability/crying
    Under 3 check-in
  19. 2022-09-17
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  20. 2022-09-22
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  21. 2022-09-29
    Survey response — day 28, dose 2, under 3
    MedDRA: Cough, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Running nose, cough
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-10-06
    Survey response — day 35, dose 2, under 3
    MedDRA: Cough, Ear infection, Office visit, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Cough, running nose, fever, ear infection · Healthcare visit (other): Pediatrician visit
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-10-06
    Report sent to call center — day 35, dose 2, under 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2022-10-07
  25. 2022-10-07
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  26. 2022-10-13
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  27. 2022-12-01
    Health check-in — 3 months, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  28. 2022-12-15
    Dose 3 — Moderna
  29. 2022-12-15
    Health check-in — day 0, dose 3, under 3
    Feeling: Fair · Sleepiness, Irritability/crying
    Under 3 check-in
  30. 2022-12-17
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Fair · Site: Pain, Redness, Swelling/hardness · Sleepiness, Irritability/crying, Loss of appetite
    Under 3 check-in
  31. 2022-12-18
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Fair · Site: Redness, Swelling/hardness · Sleepiness, Irritability/crying, Loss of appetite
    Under 3 check-in
  32. 2022-12-19
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Fair · Site: Pain · Sleepiness, Irritability/crying, Loss of appetite
    Under 3 check-in
  33. 2022-12-20
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Fair · Sleepiness, Irritability/crying
    Under 3 check-in
  34. 2022-12-21
    Health check-in — days 1–6 daily, dose 3, under 3
    Feeling: Fair · Irritability/crying
    Under 3 check-in
  35. 2022-12-24
    Health check-in — day 7, dose 3, under 3
    Feeling: Fair · Sleepiness, Irritability/crying
    Under 3 check-in
  36. 2022-12-29
    Health check-in — day 14, dose 3, under 3
    Feeling: Fair
    Under 3 check-in
  37. 2023-01-05
    Survey response — day 21, dose 3, under 3
    MedDRA: Eye discharge, Irritability, Malaise, Nasal congestion, Nasopharyngitis, Ocular hyperaemia, Office visit, Rash — Feeling: Fair · Get care from a doctor or other healthcare professional
    MedDRA releases: 2024-11
  38. 2023-01-05
    Report sent to call center — day 21, dose 3, under 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  39. 2023-01-06
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  40. 2023-01-12
    Health check-in — day 28, dose 3, under 3
    Feeling: Fair
    Under 3 check-in
  41. 2023-01-19
    Health check-in — day 35, dose 3, under 3
    Feeling: Fair
    Under 3 check-in
  42. 2023-01-30
    Health check-in — day 42, dose 3, under 3
    Feeling: Fair
    Under 3 check-in
  43. 2023-03-16
    Survey response — 3 months, dose 3, under 3
    MedDRA: Ear infection, Nasopharyngitis, Office visit, Rash — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    MedDRA releases: 2024-11
  44. 2023-03-16
    Report sent to call center — 3 months, dose 3, under 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  45. 2023-03-17
  46. 2023-06-15
    Survey response — 6 months, dose 3, under 3
    MedDRA: Hand-foot-and-mouth disease, Office visit — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    MedDRA releases: 2024-11
  47. 2023-06-15
    Call case (no matching report) — Successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  48. 2023-06-16
  49. 2023-06-16
  50. 2023-06-16
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  51. 2023-06-16
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12022-08-04Moderna No
22022-09-01Moderna No
32022-12-15Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2022-10-06 Successful
2022-10-07
 Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-01-05 Successful
2023-01-06
 Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-03-16 Successful
2023-06-16
 Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-06-15 Successful
2023-06-16
 Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 12 (Under 3) — day 7, dose 1, under 3

2022-08-11

Systemic reaction (other): Constipation, but she also just started solids.

Release 12 (Under 3) — day 28, dose 2, under 3

2022-09-29

Symptoms: Running nose, cough

Release 12 (Under 3) — day 35, dose 2, under 3

2022-10-06

Symptoms: Cough, running nose, fever, ear infection
Healthcare visit (other): Pediatrician visit

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOMalaise · · ✓
HCVOOffice visit · · ✓
SDCough · · ✓
SDEar infection · · ✓
SDEye discharge · · ✓
SDHand-foot-and-mouth disease · · ✓
SDIrritability · · ✓
SDNasal congestion · · ✓
SDNasopharyngitis · · ✓
SDOcular hyperaemia · · ✓
SDPyrexia · · ✓
SDRash · · ✓
SDRhinorrhoea · · ✓
SROConstipation · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…